Compare HTH & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HTH | PRCT |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2004 | 2021 |
| Metric | HTH | PRCT |
|---|---|---|
| Price | $39.19 | $28.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $37.50 | ★ $51.13 |
| AVG Volume (30 Days) | 443.0K | ★ 1.2M |
| Earning Date | 01-29-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ 51.72 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $1,274,536,000.00 | $299,907,000.00 |
| Revenue This Year | N/A | $48.30 |
| Revenue Next Year | $3.22 | $29.44 |
| P/E Ratio | $15.03 | ★ N/A |
| Revenue Growth | 7.30 | ★ 50.07 |
| 52 Week Low | $27.35 | $26.66 |
| 52 Week High | $40.41 | $70.80 |
| Indicator | HTH | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 69.71 | 42.78 |
| Support Level | $35.32 | $26.93 |
| Resistance Level | $40.41 | $30.02 |
| Average True Range (ATR) | 0.98 | 1.63 |
| MACD | 0.21 | 0.06 |
| Stochastic Oscillator | 78.19 | 39.86 |
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.